English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

#### The CaseA 76-year-old woman with history of diabetes mellitus, hypertension, peptic ulcer disease, and intermittent palpitations. She presents with an embolic looking occipital infarct. Her creatinine clearance is 30 ml/min, and her medications at stroke onset included statins, an oral hypoglycaemic, and an angiotensin-converting enzyme inhibitor. Work-up including MRA of the brain, neck, and aortic arch; TTE, ECG, and telemetry are unrevealing. She was placed on a 30-day cardiac monitor.#### The Questions1. Should the patient be started on an antiplatelet agent for secondary stroke prevention or oral anticoagulation for presumptive atrial fibrillation during this 30-day period?2. If anticoagulation is recommended, should she be started on warfarin, dabigatran, or rivaroxaban?3. If the 30-day cardiac event monitoring is unrevealing, should longer monitoring be considered?#### The ControversySHOULD STROKE PATIENTS WITH SUSPECTED ATRIAL FIBRILLATION BE STARTED ON ANTICOAGULATION PENDING THE RESULTS OF LONG-TERM CARDIAC MONITORING?The fact that the patient experienced intermittent palpitations, has an infarct on imaging suggesting an embolic pattern, and has no large vessel disease makes intermittent …

Stroke Patients With Suspected Atrial Fibrillation Should Be Started on Anticoagulation Pending the Results of Long-Term Cardiac Monitoring